©The Author(s) 2025.
World J Gastroenterol. Dec 28, 2025; 31(48): 111301
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.111301
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.111301
Figure 3 Gut-brain axis comparison between healthy individuals and Alzheimer's disease patients with inflammatory bowel disease.
Healthy individuals maintain intact blood-brain barrier (BBB), balanced neurotransmitters, and diverse gut microbiota, while Alzheimer’s disease patients with inflammatory bowel disease exhibit disrupted BBB, neuroinflammation, dysbiosis, and reduced short-chain fatty acids. SCFAs: Short-chain fatty acids; GABA: γ-aminobutyric acid.
- Citation: Durairajan SSK, Singh AK, Sulaiman SM, Patnaik S, Krishnamoorthi S, Iyaswamy A, Vellingiri B, Yang CB, Williams LL. Molecular links between inflammatory bowel disease and Alzheimer’s disease through immune signaling and inflammatory pathways. World J Gastroenterol 2025; 31(48): 111301
- URL: https://www.wjgnet.com/1007-9327/full/v31/i48/111301.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i48.111301